-検索条件
-検索結果
検索 (著者・登録者: moriya & s)の結果130件中、1から50件目までを表示しています

EMDB-67107: 
Cryo-EM structure of the human A2A adenosine receptor in complex with a Fab antibody fragment
手法: 単粒子 / : Miyashita Y, Konno R, Ogasawara S, Okuda Y, Takamuku Y, Moriya T, Saito T, Murata T, Ohara O, Kawashima Y

PDB-9xqb: 
Cryo-EM structure of the human A2A adenosine receptor in complex with a Fab antibody fragment
手法: 単粒子 / : Miyashita Y, Konno R, Ogasawara S, Okuda Y, Takamuku Y, Moriya T, Saito T, Murata T, Ohara O, Kawashima Y

EMDB-62652: 
The cryo-EM structure of porcine serum MGAM
手法: 単粒子 / : Tagami T, Kawasaki M, Adachi N

EMDB-62653: 
The cryo-EM structure of porcine serum MGAM bound with Acarviosyl-maltotriose.
手法: 単粒子 / : Tagami T, Kawasaki M, Adachi N

PDB-9kz6: 
The cryo-EM structure of porcine serum MGAM
手法: 単粒子 / : Tagami T, Kawasaki M, Adachi N

PDB-9kz7: 
The cryo-EM structure of porcine serum MGAM bound with Acarviosyl-maltotriose.
手法: 単粒子 / : Tagami T, Kawasaki M, Adachi N

EMDB-64381: 
Cryo-EM structure of pyrene-modified TIP60 double mutant (G12C/S50C) with addition of Nile Red
手法: 単粒子 / : Yamashita M, Kawakami N, Arai R, Ikeda A, Moriya T, Senda T, Miyamoto K

PDB-9uol: 
Cryo-EM structure of pyrene-modified TIP60 double mutant (G12C/S50C) with addition of Nile Red
手法: 単粒子 / : Yamashita M, Kawakami N, Arai R, Ikeda A, Moriya T, Senda T, Miyamoto K

EMDB-65631: 
Subtomogram average of MJ1HA S-layer
手法: サブトモグラム平均 / : Goto-Ito S, Yamagata A, Lee Y, Ehara H, Ito T

EMDB-65632: 
Subtomogram average of MJ1 attachment organelle
手法: サブトモグラム平均 / : Goto-Ito S, Yamagata A, Lee Y, Ehara H, Ito T

EMDB-60989: 
Class 2 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
手法: 単粒子 / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

EMDB-61520: 
Class 3 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
手法: 単粒子 / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

EMDB-61522: 
Class 1 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
手法: 単粒子 / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

PDB-9jj9: 
Class 3 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
手法: 単粒子 / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

PDB-9jjb: 
Class 1 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
手法: 単粒子 / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

EMDB-37440: 
Cryo-EM structure of the inhibitor-bound Vo complex from Enterococcus hirae
手法: 単粒子 / : Suzuki K, Mikuriya S, Adachi N, Kawasaki M, Senda T, Moriya T, Murata T

PDB-8wci: 
Cryo-EM structure of the inhibitor-bound Vo complex from Enterococcus hirae
手法: 単粒子 / : Suzuki K, Mikuriya S, Adachi N, Kawasaki M, Senda T, Moriya T, Murata T

EMDB-60573: 
Cryo-EM Structure of inhibitor-free hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-60574: 
Cryo-EM Structure of astemizole-bound hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-60575: 
Cryo-EM Structure of E-4031-bound hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-60576: 
Cryo-EM Structure of pimozide-bound hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyn: 
Cryo-EM Structure of inhibitor-free hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyo: 
Cryo-EM Structure of astemizole-bound hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyp: 
Cryo-EM Structure of E-4031-bound hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyq: 
Cryo-EM Structure of pimozide-bound hERG Channel
手法: 単粒子 / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-38986: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in LMNG detergent
手法: 単粒子 / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

EMDB-38987: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in nanodisc
手法: 単粒子 / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

PDB-8y6h: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in LMNG detergent
手法: 単粒子 / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

PDB-8y6i: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in nanodisc
手法: 単粒子 / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

EMDB-34741: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-34742: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgl: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgm: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33820: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33821: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33822: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33823: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33824: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33825: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33826: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 3)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33827: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 focused on RBD and NIV-13 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33828: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 1)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33829: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33830: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 3)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh6: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh7: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33643: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
手法: 単粒子 / : Uchikubo T, Shirouzu M

EMDB-33644: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
手法: 単粒子 / : Uchikubo T, Shirouzu M

PDB-7y6l: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
手法: 単粒子 / : Uchikubo T, Shirouzu M

PDB-7y6n: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
手法: 単粒子 / : Uchikubo T, Shirouzu M
ページ:
ムービー
コントローラー
構造ビューア
EMN検索について



wwPDBはEMDBデータモデルのバージョン3へ移行します
